The managements included pupillary dilatation with 1% tropicamide, replacement, operative reduction, reimplantation after vitrectomy and removement of IOLs.

• 采用托吡卡胺散瞳复位、单纯手术复位、前段玻璃体切除单纯取出再植入、更换和取出人工晶状体等方法进行处理。